DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.
Galle E, Thienpont B, Cappuyns S, Venken T, Busschaert P, Van Haele M, Van Cutsem E, Roskams T, van Pelt J, Verslype C, Dekervel J, Lambrechts D.
Galle E, et al. Among authors: roskams t.
Clin Epigenetics. 2020 Feb 14;12(1):27. doi: 10.1186/s13148-020-0821-z.
Clin Epigenetics. 2020.
PMID: 32059745
Free PMC article.